chevron_leftBack
As of 5 June 2026, Sona Nanotech Inc. has a market cap of $24.69M USD, ranking #35613 globally and #1230 in Canada.
It ranks #3937 in the Basic Materials sector, and #1056 in the Specialty Chemicals industry.
Key Stats
Market Cap
$24.69MUSD
34.31M CAD
Enterprise Value
$24.89MUSD
34.59M CAD
EBITDA (TTM)
-$1.71MUSD
-2.38M CAD
Net Income (TTM)
-$2.15MUSD
-2.99M CAD
PB Ratio
-211.5
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
David Regan
open_in_new
Founded
2013
Website
sonanano.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.2% | -1.6% | -7.7% | -27% | -55% | 1.7% |
Upcoming Earnings
Earnings Date
Fri, Jun 26
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SONA
Sona Nanotech Inc
ISIN: CA83541C1059
Shares Out.:
Shares Outstanding:
114.375M1
Shares Float:
96.826M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.3000 CAD | |
|
SONA
Sona Nanotech Inc
ISIN: CA83541C1059
|
0.3000 CAD | |
|
SNANF
Sona Nanotech Inc
ISIN: CA83541C1059
Shares Out.:
Shares Outstanding:
110.44M1
Shares Float:
92.683M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.3934 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sona Nanotech Inc.
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSX: MX
|
$4.6B
19K%
6.4B CAD
|
65.0
|
|
TSX: CHE.UN
|
$1.34B
5K%
1.87B CAD
|
13.7
|
|
TSX: NEO
|
$761.93M
3K%
1.06B CAD
|
-
|
|
TSX: MATR
|
$419.5M
2K%
583.06M CAD
|
12.2
|
|
CSE: ACT
|
$392.62M
1K%
545.71M CAD
|
-
|
|
TSX: LCFS
|
$257.15M
942%
357.42M CAD
|
108.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: LIN
|
$233.88B
947K%
|
34.5
|
|
EPA: AI
|
$121.72B
493K%
104.79B EUR
|
29.9
|
|
TSE: 4063
|
$82.16B
333K%
13.15T JPY
|
28.0
|
|
NYSE: SHW
|
$77.94B
316K%
|
30.5
|
|
NYSE: ECL
|
$72.47B
293K%
|
34.7
|
|
NYSE: APD
|
$67.35B
273K%
|
-
|
chevron_leftBack